庹吉妤,张 敏,郑荣寿.2015年中国恶性淋巴瘤发病与死亡分析[J].中国肿瘤,2021,30(1):35-40.
2015年中国恶性淋巴瘤发病与死亡分析
Analysis of Malignant Lymphoma Incidence and Mortality in China,2015
中文关键词  修订日期:2020-04-16
DOI:10.11735/j.issn.1004-0242.2021.01.A003
中文关键词:  恶性淋巴瘤  死亡率  发病率  中国
英文关键词:malignant lymphoma  mortality  incidence  China
基金项目:科技部基础工作专项(2014FY121100);中国医学科学院医学与健康科技创新工程(2018-12M-3-003)
作者单位
庹吉妤 湖北省肿瘤医院 
张 敏 湖北省肿瘤医院 
郑荣寿 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院 
摘要点击次数: 1419
全文下载次数: 339
中文摘要:
      摘 要:[目的]分析和描述2015年中国恶性淋巴瘤的发病与死亡情况。[方法] 整理分析2015年符合质量要求的368个肿瘤登记处的恶性淋巴瘤发病与死亡资料,结合人口数据,估算2015年中国恶性淋巴瘤发病和死亡人数。采用2000年中国标准人口年龄构成和Segi’s世界标准人口年龄构成,计算中国2015年恶性淋巴瘤发病和死亡的中国人口标化率(中标率)和世界人口标化率(世标率)。[结果] 2015年中国恶性淋巴瘤新发病例约8.95万例,占所有恶性肿瘤发病的2.28%,粗发病率为6.52/10万,发病中标率为4.57/10万,世标率为4.48/10万,0~74岁累积率为0.51%。男女合计及男、女性年龄别发病率高峰值均出现在75~79岁年龄组。2015年中国恶性淋巴瘤死亡约4.98万例,占所有恶性肿瘤死亡的2.13%。恶性淋巴瘤粗死亡率为3.62/10万,中标率为2.39/10万,世标率为2.36/10万,0~74岁累积率为0.27%。恶性淋巴瘤发病率和死亡率均表现为男性高于女性,城市高于农村。[结论] 我国恶性淋巴瘤的发病率和死亡率低于全球平均水平,存在性别和城乡差异。与2009年相比,男性恶性淋巴瘤发病高峰提前。
英文摘要:
      Abstract:[Purpose] To analyze the incidence and mortality of malignant lymphoma in China in 2015.[Methods] The malignant lymphoma data from 368 cancer registries were qualified for the analysis. According to the national population data,the number of new cases and deaths of malignant lymphoma in China in 2015 were estimated. The incidence and mortality of malignant lymphoma in China in 2015 were calculated and adjusted by Chinese standard population in 2000(ASIRC,ASMRC) and world Segi’s standard population(ASIRW,ASMRW). [Results] It was estimated that 89 500 new cases of malignant lymphoma occurred in China,which accounted for 2.28% of all new cancer cases in 2015. The crude incidence of malignant lymphoma in China was 6.52/105. While the ASIRC and ASIRW were 4.57/105 and 4.48/105,respectively. The cumulative incidence(0~74 years old) was 0.51%. The age-specific incidence rate of malignant lymphoma peaked at the age group of 75~79 years in both gender. There were estimated 49 800 death cases of malignant lymphoma in China which accounted for 2.13% of all cancer deaths. The crude mortality rate of malignant lymphoma was 3.62/105. The ASMRC and ASMRW were 2.39/105 and 2.36/105,respectively. The cumulative mortality(0~74 years old) was 0.27%.The incidence and mortality of malignant lymphoma were higher in males than in females,and higher in urban than in rural areas.[Conclusion] There are gender and urban-rural differences in the incidence and mortality of malignant lymphoma in China,which are lower than the global average level. Compared with the year of 2009,the male peak age of malignant lymphoma comes earlier in 2015.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器